Skip to Main Content

Paper Details

Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy.
Clin Cancer Res
1
2024
C1RL, CFHR3, CRP, LAMC1, LBP, LDHB, LYVE1, PD-1, PXDN, S100A8, S100A9, SAA1, SAA2, SERPINE1, VCAN, advanced melanoma, anti-, melanoma, metastatic melanoma, neutrophil, patient, patients, primary melanoma tumor cells
Author NameAffiliation
Phil F ChengUniversity Hospital of Zurich
Phil F ChengUniversity Hospital of Zurich
Alexander LeitnerETH Zurich
Alexander LeitnerETH Zurich
Ludovic GilletETH Zurich
Sandra GoetzeETH Zurich
Bernd WollscheidETH Zurich
Reinhard DummerUniversity Hospital of Zurich
Reinhard DummerUniversity Hospital of Zurich
Ruedi Aebersold
Ruedi Aebersold
  • 1 - 11

Datasets

Release 1.2